Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice
Open Access
- 31 July 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 1727
Abstract
Paracoccidioidomycosis (PCM) is an endemic mycosis in Latin American caused by the thermodimorphic fungi of the genus Paracoccidioides spp. Notably, a Th1 immune response is required to control PCM. In this context, dendritic cells (DCs) seem to be essential players in capture, processing and presentation of Paracoccidioides antigens to naïve T cells and their further activation. We have previously demonstrated that differentiated DCs from bone marrow cells, pulsed with the immunoprotective peptide 10 (P10), effectively control experimental PCM immunocompetent and immunosuppressed mice. However, this procedure may not be infeasible or it is limited for the therapy of human patients. Therefore, we have sought a less invasive but equally effective approach that would better mimics the autologous transplant of DC in a human patient. Here, we isolated and generated monocyte differentiated dendritic cells (MoDCs) from infected mice, pulsed them with P-10, and used them in the therapy of PCM in syngeneic mice. Similar to the results using BMDCs, the P10-pulsed MoDCs stimulated the proliferation of CD4+ T lymphocytes, induced a mixed production of Th1/Th2 cytokines and decreased the fungal burden in murine lungs in the setting of PCM. The process of differentiating MoDCs derived from an infected host, and subsequently used for therapy of PCM is much simpler than that for obtaining BMDCs, and represents a more reasonable approach to treat patients infected with Paracoccidioides. The results presented suggest that P10-primed MoDC may be a promising strategy to combat complicated PCM as well as to significantly shorten the lengthy requirements for treatment of patients with this fungal disease.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Foundation for the National Institutes of Health
This publication has 36 references indexed in Scilit:
- Inflammatory dendritic cells in mice and humansTrends in Immunology, 2013
- Prophylactic and Therapeutic Vaccination Using Dendritic Cells Primed with Peptide 10 Derived from the 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensisClinical and Vaccine Immunology, 2012
- Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infectionJournal of Experimental Medicine, 2009
- Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defenceClinical Microbiology and Infection, 2006
- Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signalingBlood, 2004
- Regulation of Dendritic Cell Migration to the Draining Lymph NodeJournal of Experimental Medicine, 2003
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Support of Paracoccidioides brasiliensis multiplication by human monocytes or macrophages: inhibition by activated phagocytesJournal of Medical Microbiology, 1994
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.Journal of Experimental Medicine, 1992